Bruker Corporation (BRKRP) vs Krystal Biotech, Inc. (KRYS)
A side-by-side comparison of Bruker Corporation and Krystal Biotech, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BRKRP
Bruker Corporation
$437.31HealthcareDelayed quote: Oct 6, 2026, 10:46 AM EDT
KRYS
Krystal Biotech, Inc.
$325.42HealthcareDelayed quote: Oct 6, 2026, 11:00 AM EDT
Total return — BRKRP vs KRYS
growth of $100 · dividends reinvested · last 1yBRKRP +94.8% (+94.8%/yr)KRYS +122.9% (+122.9%/yr)KRYS compounded faster over this window
BRKRP KRYS
BRKRP vs KRYS: by the numbers
- •KRYS is the larger company ($9.59B vs $8.77B market cap).
- •KRYS is profitable (54.82% net margin) while BRKRP runs a net loss (-2.03%).
- •BRKRP pays a dividend (3.35% yield), while KRYS has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BRKRP | KRYS |
|---|---|---|
| P/E ratio | N/A | 40.78 |
| Forward P/E | 206.08 | 42.78 |
| P/S ratio | 2.51 | 21.78 |
| P/B ratio | 3.66 | 7.06 |
| EV / EBITDA | 29.46 | 44.89 |
| FCF yield | 1.07% | 2.69% |
Profitability
| Metric | BRKRP | KRYS |
|---|---|---|
| Gross margin | 46.69% | 93.34% |
| Operating margin | 3.61% | 44.93% |
| Net margin | -2.03% | 54.82% |
| ROE | -2.97% | 17.77% |
| ROIC | 2.56% | 14.41% |
Dividends
| Metric | BRKRP | KRYS |
|---|---|---|
| Dividend yield | 3.35% | N/A |
Growth (annualized)
| Metric | BRKRP | KRYS |
|---|---|---|
| Revenue CAGR (5Y) | 9.10% | N/A |
| FCF CAGR (5Y) | -21.33% | N/A |
| Total return CAGR (5Y) | N/A | 44.28% |
Frequently asked
- Does BRKRP or KRYS pay a bigger dividend?
- BRKRP pays a dividend (3.35% yield), while KRYS has no payments in the available dividend history.
- Is BRKRP or KRYS more profitable?
- KRYS runs the higher net margin — BRKRP at -2.03% versus KRYS at 54.82%.
Go deeper
Dig into the metrics
Krystal Biotech P/E ratioBruker dividend yieldBruker ROEKrystal Biotech ROEBruker operating marginKrystal Biotech operating marginBruker revenue growthKrystal Biotech revenue growthBruker free cash flowKrystal Biotech free cash flow
Bruker & Krystal Biotech appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.